[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 21st Science Board Meeting
Press Release
Date and Time:January 13, 2017 from 10am to 12pm
Agenda / List of Handouts
Agenda
- Lectures and exchange of opinions about Subcommittee 3 (AI:Artificial Intelligence)
- Tokyo university Dr. Matsuo lecture
- Tokyo university Dr. Suda lecture
- Utilization of new elements different from conventional technology to medical devices
- Recent activities of the Science Board Subcommittees
- Subcommittee 1 (Rare Cancers)
- Subcommittee 2 (Pharmaceutical Development)
List of Handouts
- Document 1 Subcommittee 3 (AI:Artificial Intelligence) scope
- Document 2 Dr. Matsuo lecture explanatory material
- Document 3 Dr. Suda lecture explanatory material
- Document 4 Recent activities of the Science Board Subcommittee
- Document 5 Addition of a new member to the Subcommittee 2 (Pharmaceutical Development)(draft)